Deryk G Jones

Title: Deryk G Jones: Innovator in Chondrocyte Research

Introduction

Deryk G Jones is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of biomedical research, particularly in the area of chondrocyte stimulation. With a total of 2 patents, his work has implications for cartilage repair and regenerative medicine.

Latest Patents

One of Deryk G Jones's latest patents is focused on Thyroid-derived chondrocyte-stimulating factor (TDCSF). This high molecular weight complex, which exceeds 500 kd, consists of proteinaceous subunits that can be partially dissociated into active portions using 8M urea. TDCSF is known to stimulate the growth of articular chondrocytes and synovial fibroblasts under serum-free conditions. It serves as a serum substitute for the culture of chondrocytes and fibroblasts in vitro, aids in the development of cartilage implants, and has potential applications in vivo for repairing cartilage and bone defects as well as treating degenerative joint diseases. Additionally, TDCSF is stabilized in the presence of reducing agents for disulfide bonds, and antibodies and conjugates for TDCSF are also disclosed in his patent.

Career Highlights

Deryk G Jones is affiliated with Leland Stanford Junior University, where he continues to advance his research in the field of chondrocyte stimulation and regenerative medicine. His innovative work has garnered attention and respect within the scientific community.

Collaborations

Deryk G Jones collaborates with R Lane Smith, contributing to the advancement of their shared research interests.

Conclusion

Deryk G Jones is a prominent inventor whose work in chondrocyte research has the potential to significantly impact the field of regenerative medicine. His patents and ongoing research efforts continue to pave the way for advancements in cartilage repair and treatment.